• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    11.62 0.00(0.00%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:11.62
    Open:11.36
    Bid:10.20 x 100
    Ask:11.60 x 100
    1y Target Est:16.77
    Beta:0.754144
    Earnings Date:Nov 3 - Nov 9 (Est.)
    Day's Range:11.28 - 11.71
    52wk Range:3.92 - 15.01
    Volume:3,788,309
    Avg Vol (3m):4,614,990
    Market Cap:3.13B
    P/E (ttm):N/A
    EPS (ttm):-0.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAX 0.00%3.13B
    MRKUp 0.76%155.96B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):80.43
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.38
    Quarterly EPS Est (Sep-15) :-0.09
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback